Global Drug Discovery Outsourcing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Drug Discovery Outsourcing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Type (Medical Chemistry Service, and Biology Service), Drug Type (Small Molecule, and Large Molecules (Biopharmaceuticals)), Therapeutic Area (Oncology, Infectious Disease, Respiratory Disease, Cardiovascular, Gastrointestinal, and Others), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Drug Discovery Outsourcing Market was valued at USD 3,875.0 million in 2023 and is expected to reach USD 6,365.1 million by 2031 while growing at a CAGR of 6.4% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global drug discovery outsourcing market growth. Drug discovery outsourcing involves outsourcing different stages of the complex and resource-intensive drug discovery process to external organizations, commonly specialized contract research organizations (CROs) or other service providers. This process encompasses key stages like target identification and validation, hit identification, lead optimization, preclinical development, and clinical trials in the quest for new therapeutic agents.
Increasing complexity in drug discovery and rising R&D expenditures are anticipated to drive growth in the drug discovery outsourcing market. However, challenges such as the high cost of drug development and intellectual property concerns may impede market expansion.
Furthermore, the global drug discovery outsourcing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Type Analysis
The Global Drug Discovery Outsourcing Market is segmented among Medical Chemistry Service, and Biology Service, based on type. In 2023, Medical Chemistry Service accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Drug Type Analysis
The Global Drug Discovery Outsourcing Market is segmented among Small Molecule, and Large Molecules (Biopharmaceuticals), based on Drug Type. In 2023, Small Molecule accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Drug Discovery Outsourcing Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Charles River Laboratories International, Inc., GenScript Biotech Corporation, Curia Inc. , Dalton Pharma Services, Evotec SE, Thermo Fisher Scientific (PPD, Inc.), Oncodesign, Jubilant Life Sciences Limited, Eurofins Scientific, and WuXi AppTec.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Drug Discovery Outsourcing Market Dynamics
Drivers
Restraints
Opportunity
4. Global Drug Discovery Outsourcing Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Drug Discovery Outsourcing Market Segmentation, By Type
Global Drug Discovery Outsourcing Market Share Analysis, By Type
Global Drug Discovery Outsourcing Market Growth Analysis, By Type
Global Drug Discovery Outsourcing Market Trends, By Type
o Medical Chemistry Service
o Biology Service
6. Global Drug Discovery Outsourcing Market Segmentation, By Drug Type
Global Drug Discovery Outsourcing Market Share Analysis, By Drug Type
Global Drug Discovery Outsourcing Market Growth Analysis, By Drug Type
Global Drug Discovery Outsourcing Market Trends, By Drug Type
o Small Molecule
o Large Molecules (Biopharmaceuticals)
7. Global Drug Discovery Outsourcing Market Segmentation, By Therapeutic Area
Global Drug Discovery Outsourcing Market Share Analysis, By Therapeutic Area
Global Drug Discovery Outsourcing Market Growth Analysis, By Therapeutic Area
Global Drug Discovery Outsourcing Market Trends, By Therapeutic Area
o Oncology
o Infectious Disease
o Respiratory Disease
o Cardiovascular
o Gastrointestinal
o Others
8. Global Drug Discovery Outsourcing Market Segmentation, By Region
Global Drug Discovery Outsourcing Market Share Analysis, By Region
Global Drug Discovery Outsourcing Market Growth Analysis, By Region
Global Drug Discovery Outsourcing Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Charles River Laboratories International, Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
GenScript Biotech Corporation
Curia Inc.
Dalton Pharma Services
Evotec SE
Thermo Fisher Scientific (PPD, Inc.)
Oncodesign
Jubilant Life Sciences Limited
Eurofins Scientific
WuXi AppTec
*Similar analysis will be provided for each company listed above.
